19
VI. Literaturverzeichnis
BORNHOLDT, J., S. FRIIS, S. GODIKSEN, S. S. POULSEN, E. SANTONI-RUGIU, H. C. BISGAARDT, I. M. LOTHE, T. IKDAHL, K. M. TVEIT, E. JOHNSON, E. H.
KURE u. L. K. VOGEL (2011):
The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.
BMC Cancer 11, 65
DA COSTA, A., B. KOHN, A. D. GRUBER u. R. KLOPFLEISCH (2013):
Multiple RT-PCR markers for the detection of circulating tumour cells of metastatic canine mammary tumours.
Vet J 196, 34-39
DE OLIVEIRA, S. S., I. M. DE OLIVEIRA, W. DE SOUZA u. J. A. MORGADO-DÍAZ (2005):
Claudins upregulation in human colorectal cancer.
FEBS Lett 579, 6179-6185
ERSOZ, S., S. MUNGAN, U. COBANOGLU, H. TURGUTALP u. Y. OZORAN (2011):
Prognostic importance of Claudin-1 and Claudin-4 expression in colon carcinomas.
Pathol Res Pract 207, 285-289
ESCUDERO-ESPARZA, A., W. G. JIANG u. T. A. MARTIN (2011):
The Claudin family and its role in cancer and metastasis.
Front Biosci 16, 1069-1083
FARQUHAR, M. G. u. G. E. PALADE (1963):
Junctional complexes in various epithelia.
J Cell Biol 17, 375-412
FUJITA, K., J. KATAHIRA, Y. HORIGUCHI, N. SONODA, M. FURUSE u. S.
TSUKITA (2000):
Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein.
FEBS Lett 476, 258-261
FURUSE, M., H. SASAKI, K. FUJIMOTO u. S. TSUKITA (1998):
A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts.
J Cell Biol 143, 391-401
VI. Literaturverzeichnis
20
GAO, Z., X. XU, B. MCCLANE, Q. ZENG, B. LITKOUHI, W. R. WELCH, R. S.
BERKOWITZ, S. C. MOK u. E. I. GARNER (2011):
C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin.
Clin Cancer Res 17, 1065-1074 GUMBINER, B. (1987):
Structure, biochemistry, and assembly of epithelial tight junctions.
Am J Physiol 253, C749-758
HAMMER, S. C., A. BECKER, K. RATEITSCHAK, A. MOHR, F. LÜDER RIPOLI, S.
HENNECKE, J. JUNGINGER, M. HEWICKER-TRAUTWEIN, B. BRENIG, A.
NGEZAHAYO, I. NOLTE u. H. MURUA ESCOBAR (2016a):
Longitudinal claudin gene expression analyses in canine mammary tissues and thereof derived primary cultures and cell lines.
Int J Mol Sci 17, 1655
HAMMER, S. C., S. NAGEL, J. JUNGINGER, M. HEWICKER-TRAUTWEIN, S.
WAGNER, A. HEISTERKAMP, A. NGEZAHAYO, I. NOLTE u. H. M. ESCOBAR (2016b):
Claudin-1, -3, -4 and -7 gene expression analyses in canine prostate carcinoma and mammary tissue derived cell lines.
Neoplasma 63, 231-238
JAKAB, C., J. HALASZ, A. M. SZASZ, E. BATMUNKH, A. KISS, Z. SCHAFF, M.
RUSVAI, P. GÁLFI u. J. KULKA (2008a):
Expression and localisation of claudin-1, -2, -3, -4, -5, -7 and -10 proteins in the normal canine mammary gland.
Acta Vet Hung 56, 341-352
JAKAB, C., J. HALÁSZ, A. M. SZÁSZ, A. KISS, Z. SCHAFF, M. RUSVAI, P. GÁLFI u. J. KULKA (2008b):
Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
J Comp Path 139, 238-245
JAKAB, C., M. RUSVAI, Z. SZABÓ, Á. SZABÁRA u. J. KULKA (2009):
Expression of the claudin-4 molecule in benign and malignant canine hepatoid gland tumors.
Acta Vet Hung 57, 463-475
JAKAB, C., M. RUSVAI, P. GALFI, M. MÁNDOKI, Z. DEMETER, Z. SZABÓ u. J.
KULKA (2010a):
Expression of claudin-5 in hepatoid gland biopsies.
Vet Dermatol 21, 276-281
VI. Literaturverzeichnis
21
JAKAB, C., M. RUSVAI, P. GÁLFI, Z. SZABÓ, Á. SZABÁRA u. J. KULKA (2010b):
Expression of claudin-1, -3, -4, -5 and -7 proteins in low grade colorectal carcinoma of canines.
Histol Histopathol 25, 55-62
JAKAB, C., M. RUSVAI, Z. DEMETER, P. GÁLFI, Z. SZABÓ u. J. KULKA (2011a):
Expression of claudin-4 molecule in canine exocrine pancreatic acinar cell carcinomas.
Histol Histopathol 26, 1121-1126
JAKAB, C., M. RUSVAI, P. GALFI, J. HALASZ u. J. KULKA (2011b):
Expression of claudin-5 in canine pancreatic acinar cell carcinoma - an immunohistochemical study.
Acta Vet Hung 59, 87-98
KOMINSKY, S. L., P. ARGANI, D. KORZ, E. EVRON, V. RAMAN, E. GARRETT, A.
REIN, G. SAUTER, O. P. KALLIONIEMI u. S. SUKUMAR (2003):
Loss of tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Oncogene 22, 2021-2033
KOMINSKY, S. L., M. VALI, D. KORZ, T. G. GABIG, S. A. WEITZMAN, P. ARGANI u. S. SUKUMAR (2004):
Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.
Am J Pathol 164, 1627-1633
KONDOH, M., A. MASUYAMA, A. TAKAHASHI, N. ASANO, H. MIZUGUCHI, N.
KOIZUMI, M. FUJII, T. HAYAKAWA, Y. HORIGUCHI u. Y. WATANBE (2005):
A novel strategy for the enhancement of drug absorption using a claudin modulator.
Mol Pharmacol 67, 749-756
KONO, T., M. KONDOH, D. KYUNO, T. ITO, Y. KIMURA, M. IMAMURA, T. KOHNO, T. KONNO, T. FURUHATA, N. SAWADA, K. HIRATA u. T. KOJIMA (2015):
Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway.
Pharmacol Res Perspect 3, e00196
KRAJEWSKA, M., A. H. OLSON, D. MERCOLA, J. C. REED u. S. KRAJEWSKI (2007):
Claudin-1 immunohistochemistry for distinguishing malignant from benign epithelial lesions of prostate.
Prostate 67, 907-910
VI. Literaturverzeichnis
22
LONG, H., C. D. CREAN, W.-H. LEE, O. W. CUMMINGS u. T. G. GABIG (2001):
Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.
Cancer Res 61, 7878-7881
MICHL, P., M. BUCHHOLZ, M. ROLKE, S. KUNSCH, M. LÖHR, B. MCCLANE, S.
TSUKITA, G. LEDER, G. ADLER u. T. M. GRESS (2001):
Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.
Gastroenterology 121, 678-684
NACHT, M., A. T. FERGUSON, W. ZHANG, J. M. PETROZIELLO, B. P. COOK, Y.
HONG GAO, S. MAGUIRE, D. RILEY, G. COPPOLA, G. M. LANDES, S. L.
MADDEN u. S. SUKUMAR (1999):
Combining serial analysis of gene expression and array techologies to identify genes differentially expressed in breast cancer.
Cancer Res 59, 5464-5470
NAKAGAWA, S., N. MIYOSHI, H. ISHII, K. MIMORI, F. TANAKA, M. SEKIMOTO, Y.
DOKI u. M. MORI (2011):
Expression of CLDN1 in colorectal cancer: a novel marker for prognosis.
Int J Oncol 39, 791-796
OSHIMA, T., C. KUNISAKI, K. YOSHIHARA, R. YAMADA, N. YAMAMOTO, T.
SATO, H. MAKINO, S. YAMAGISHI, Y. NAGANO, S. FUJII, M. SHIOZAWA, M.
AKAIKE, N. WADA, Y. RINO, M. MASUDA, K. TANAKA u. T. IMADA (2008):
Reduced expression of claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer.
Oncol REP 19, 953-959
SANTIN, A. D., S. CANÉ, S. BELLONE, M. PALMIERI, E. R. SIEGEL, M. THOMAS, J. J. ROMAN, A. BURNETT, M. J. CANNON u. S. PECORELLI (2005):
Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Cancer Res 65, 4334-4342
SHEEHAN, G. M., B. V. S. KALLAKURY, C. E. SHEEHAN, H. A. G. FISHER, R. P.
KAUFMANN JR. u. J. S. ROSS (2007):
Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas.
Hum Pathol 38, 564-569
VI. Literaturverzeichnis
23
SONODA, N., M. FURUSE, H. SASAKI, S. YONEMURA, J. KATAHIRA, Y.
HORIGUCHI u. S. TSUKITA (1999):
Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier.
J Cell Biol 147, 195-204
TAKAHASHI, A., Y. SAITO, M. KONDOH, K. MATSUSHITA, S. M. KRUG, H.
SUZUKI, H. TSUJINO, X. LI, H. AOYAMA, K. MATSUHISA, T. UNO, M. FROMM, T.
HAMAKUBO u. K. YAGI (2012):
Creation and biochemical analysis of a broad-specific claudin binder.
Biomaterials 33, 3464-3474
TODD, M. C., H. M. PETTY, J. M. KING, B. N. PIANA MARSHALL, R. A. SHELLER u. M. E. CUEVAS (2015):
Overexpression and delocalization of claudin-3 protein in MCF-7 and MDA-MB-415 breast cancer cell lines.
Oncol Lett 10, 156-162
UCHIDA, H., M. KONDOH, T. HANADA, A. TAKAHASHI, T. HAMAKUBO u. K. YAGI (2010):
A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide.
Biochem Pharmacol 79, 1437-1444
UEDA, J., S. SEMBA, H. CHIBA, N. SAWADA, Y. SEO, M. KASUGA u. H.
YOKOZAKI (2007):
Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis.
Pathobiology 74, 32-41
WINKLER, S., H. MURUA ESCOBAR, N. EBERLE, N. REIMANN-BERG, I. NOLTE u. J. BULLERDIEK (2005):
Establishment of a cell line derived from a canine prostate carcinoma with a highly rearranged karyotype.
J Hered 96, 782-785
YUAN, X., X. LIN, G. MANOREK, I. KANATANI, L. H. CHEUNG, M. G.
ROSENBLUM u. S. B. HOWELL (2009):
Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors.
Mol Cancer Ther 8, 1906-1015